Inventor · disambiguated record
Michael R. Myers
Also filed as: MYERS MICHAEL · MYERS MICHAEL R · MYERS MICHAEL RAY
51 granted patents·8 pending applications·5,268 citations·filing 1992–2022
99Inventor score
Files withRHONE POULENC RORER PHARMA14AVENTIS PHARMA INC10AVENTIS PHARMA SA7INNOCOLL PHARM LTD7AVENTIS PHARM PROD INC4
Top patents by PatentIndex Score
59 records- 0199US6528526B1Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinasesAVENTIS PHARMA INC·Filed 2000·Granted Mar 4, 2003·305 cites·37 claims
- 0299US6180632B1Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinasesAVENTIS PHARM PROD INC·Filed 1998·Granted Jan 30, 2001·395 cites·79 claims
- 0399US6057320ABis mono-and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinaseAVENTIS PHARM PROD INC·Filed 1997·Granted May 2, 2000·148 cites·13 claims
- 0499USRE36256EBis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinaseRHONE POULENC RORER PHARMA·Filed 1997·Granted Jul 20, 1999·183 cites·20 claims
- 0599US5646153ABis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinaseRHONE POULENC RORER PHARMA·Filed 1995·Granted Jul 8, 1997·259 cites·18 claims
- 0699US5480883ABis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinaseRHONE POULENC RORER PHARMA·Filed 1993·Granted Jan 2, 1996·383 cites·20 claims
- 0798US6482834B2Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinasesAVENTIS PHARMA INC·Filed 2001·Granted Nov 19, 2002·254 cites·50 claims
- 0898US6479479B2Azetidine derivatives, their preparation and pharmaceutical compositions containing themAVENTIS PHARMA SA·Filed 2001·Granted Nov 12, 2002·81 cites·58 claims
- 0998US6245760B1Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinasesAVENTIS PHARM PROD INC·Filed 1998·Granted Jun 12, 2001·257 cites·57 claims
- 1098US5710158AAryl and heteroaryl quinazoline compounds which inhibit EGF and/or PDGF receptor tyrosine kinaseRHONE POULENC RORER PHARMA·Filed 1994·Granted Jan 20, 1998·339 cites·14 claims
- 1198US5561134ACompounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic propertiesRHONE POULENC RORER PHARMA·Filed 1994·Granted Oct 1, 1996·143 cites·26 claims
- 1298US5364862ACompounds having antihypertensive and anti-ischemic propertiesRHONE POULENC RORER PHARMA·Filed 1992·Granted Nov 15, 1994·141 cites·18 claims
- 1397US6355631B1Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and their preparationAVENTIS PHARMA SA·Filed 2001·Granted Mar 12, 2002·107 cites·21 claims
- 1497US6159978AQuinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinasesAVENTIS PHARM PROD INC·Filed 1998·Granted Dec 12, 2000·203 cites·36 claims
- 1597US5721237AProtein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation propertiesRHONE POULENC RORER PHARMA·Filed 1995·Granted Feb 24, 1998·245 cites·13 claims
- 1697US5714493AAryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinaseRHONE POULENC RORER PHARMA·Filed 1994·Granted Feb 3, 1998·176 cites·1 claims
- 1797US5656643ABis mono-and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinaseRHONE POULENC RORER PHARMA·Filed 1995·Granted Aug 12, 1997·258 cites·4 claims
- 1897US5409930ABis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinaseRHONE POULENC RORER PHARMA·Filed 1992·Granted Apr 25, 1995·314 cites·13 claims
- 1995US8606418B1Wind prediction for wind farms through the use of weather radarMYERS MICHAEL R·Filed 2011·Granted Dec 10, 2013·59 cites·22 claims
- 2095US5795889ABis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinaseRHONE POULENC RORER PHARMA·Filed 1995·Granted Aug 18, 1998·59 cites·17 claims
- 2194US6566356B2Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparationAVENTIS PHARMA SA·Filed 2001·Granted May 20, 2003·60 cites·18 claims
- 2293US7265111B2Adenosine analogues and their use as pharmaceutical agentsSANOFI AVENTIS DEUTSCHLAND·Filed 2003·Granted Sep 4, 2007·79 cites·14 claims
- 2393US6645969B1Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinaseAVENTIS PHARMA INC·Filed 1995·Granted Nov 11, 2003·74 cites·12 claims
- 2493USRE37650EAryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinaseAVENTIS PHARMACETICAL PRODUCTS·Filed 1994·Granted Apr 9, 2002·88 cites·5 claims
- 2592US6734176B2Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparationAVENTIS PHARMA SA·Filed 2002·Granted May 11, 2004·47 cites·9 claims
- 2692US5736554ACompounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic propertiesRHONE POULENC RORER PHARMA·Filed 1995·Granted Apr 7, 1998·102 cites·8 claims
- 2791US6846815B2Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinasesAVENTIS PHARMA INC·Filed 2003·Granted Jan 25, 2005·28 cites·18 claims
- 2891US6581262B1Installation tool for irrigation emitter barbsFiled 2002·Granted Jun 24, 2003·79 cites·3 claims
- 2990US7946010B1Installation tool for irrigation emitter barbs and tubing punchECM IND LLC·Filed 2010·Granted May 24, 2011·38 cites·5 claims
- 3090US7185409B1Installation tool for irrigation emitter barbs with cutterMYERS MICHAEL·Filed 2005·Granted Mar 6, 2007·39 cites·1 claims
- 3190US6872717B2Pharmacological uses of azetidine derivativesAVENTIS PHARMA SA·Filed 2002·Granted Mar 29, 2005·35 cites·13 claims
- 3287US6559313B2Compounds having antihypertensive, cardioprotective anti-ischemic and antilipolytic propertiesAVENTIS PHARMA GMBH·Filed 2002·Granted May 6, 2003·21 cites·2 claims
- 3386US5652366ADI (1R)-(-)camphosulfonic acid) salt, preparation thereof and use thereofRHONE POULENC RORER PHARMA·Filed 1995·Granted Jul 29, 1997·93 cites·2 claims
- 3484US6696434B2Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinasesAVENTIS PHARMA INC·Filed 2002·Granted Feb 24, 2004·14 cites·62 claims
- 3583US5893201AInstallation tool for irrigation emitter barbsFiled 1997·Granted Apr 13, 1999·42 cites·10 claims
- 3682US6376472B1Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic propertiesAVENTIS PHARMA INC·Filed 1998·Granted Apr 23, 2002·24 cites·15 claims
- 3780USRE47826EDrug delivery device for providing local analgesia, local anesthesia or nerve blockageINNOCOLL PHARM LTD·Filed 2015·Granted Jan 28, 2020·3 cites·42 claims
- 3880US7998977B2Inhibitors of AKT (protein kinase B)LILLY CO ELI·Filed 2007·Granted Aug 16, 2011·7 cites·16 claims
- 3979US8034368B2Drug delivery device for providing local analgesia, local anesthesia or nerve blockageINNOCOLL TECHNOLOGIES LTD·Filed 2008·Granted Oct 11, 2011·7 cites·23 claims
- 4078US7132414B2Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparationAVENTIS PHARMA SA·Filed 2004·Granted Nov 7, 2006·9 cites·6 claims
- 4177US5722142AInstallation tool for irrigation emitter barbsFiled 1997·Granted Mar 3, 1998·33 cites·9 claims
- 4274US10487134B2Modified collagenINNOCOLL PHARM LTD·Filed 2013·Granted Nov 26, 2019·3 cites·17 claims
- 4372US2022213173A1Modified collagenINNOCOLL PHARM LTD·Filed 2022·Application pending·0 cites
- 4471US6852712B2Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinasesAVENTIS PHARMA INC·Filed 2003·Granted Feb 8, 2005·3 cites·13 claims
- 4571US5476851APyrazolo[3,4-g]quinoxaline compounds which inhibit PDGF receptor protein tyrosine kinaseRHONE POULENC RORER PHARMA·Filed 1994·Granted Dec 19, 1995·25 cites·24 claims
- 4669US6821962B2Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and /or p56lck tyrosine kinasesAVENTIS PHARMA INC·Filed 2003·Granted Nov 23, 2004·2 cites·37 claims
- 4767US11623947B2Collagen powderINNOCOLL PHARM LTD·Filed 2013·Granted Apr 11, 2023·1 cites·26 claims
- 4867US7612075B2Substituted oxoazaheterocyclyl compoundsAVENTIS PHARMA INC·Filed 2003·Granted Nov 3, 2009·3 cites·15 claims
- 4965US11746141B2Modified collagenINNOCOLL PHARM LTD·Filed 2019·Granted Sep 5, 2023·0 cites·14 claims
- 5059US7550597B2Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinasesAVENTIS PHARMA INC·Filed 2005·Granted Jun 23, 2009·0 cites·6 claims
Showing the top 50 of 59 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Michael R. Myers files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →